Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Slack

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Leukemia & Lymphoma|July 12, 2014
Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantationNandita Khera, Yu-Hui Chang, James Slack, et al.
Blood|January 24, 2012
RNAi screening of the kinome with cytarabine in leukemiasRaoul Tibes, James M Bogenberger, Leena Chaudhuri, et al.
Cancer|March 15, 2006
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized studyHagop Kantarjian, Jean-Pierre J Issa, Craig S Rosenfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502Steven M Devine, Kouros Owzar, William Blum, et al.
Blood Cancer Journal|October 6, 2025
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patientsAli Alsugair, Estefania Gauto Mariotti, Mohammad M Alhousani, et al.
The Journal of Allergy and Clinical Immunology|April 11, 2017
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disordersJames Slack, Michael H Albert, Dmitry Balashov, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Leukemia & Lymphoma|July 12, 2014
Impact of race and ethnicity on outcomes and health care utilization after allogeneic hematopoietic cell transplantationNandita Khera, Yu-Hui Chang, James Slack, et al.
Blood|January 24, 2012
RNAi screening of the kinome with cytarabine in leukemiasRaoul Tibes, James M Bogenberger, Leena Chaudhuri, et al.
Cancer|March 15, 2006
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized studyHagop Kantarjian, Jean-Pierre J Issa, Craig S Rosenfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502Steven M Devine, Kouros Owzar, William Blum, et al.
Blood Cancer Journal|October 6, 2025
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patientsAli Alsugair, Estefania Gauto Mariotti, Mohammad M Alhousani, et al.
The Journal of Allergy and Clinical Immunology|April 11, 2017
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disordersJames Slack, Michael H Albert, Dmitry Balashov, et al.
Pageof 2